Literature DB >> 8139268

Oxidative stress induces adult T cell leukemia derived factor/thioredoxin in the rat retina.

A Ohira1, O Honda, C D Gauntt, M Yamamoto, K Hori, H Masutani, J Yodoi, Y Honda.   

Abstract

BACKGROUND: Adult T cell leukemia derived factor (ADF), originally defined as an interleukin-2 receptor inducer, is a human thioredoxin homolog. ADF/thioredoxin has several biologic functions, such as defense against cellular damage, activity to scavenge oxidative stress by hydrogen peroxide radicals and cytokine-like properties. We hypothesized that under certain conditions, ischemia followed by reperfusion and/or light exposure, ADF may be induced in the retina. EXPERIMENTAL
DESIGN: To test this hypothesis, we prepared experimental animal models in which oxidative stress could be applied to the retina. In the present study, we examined ADF expression in the rat retina using temporary ischemia and reperfusion, and photodynamic retinal vascular thrombosis by immunohistochemical and Western blotting methods.
RESULTS: ADF expression was strongly induced in the retinal pigment epithelial cells after 2 hours of ischemia followed by 2, 24, or 48 hours of reperfusion. ADF was also expressed in retinal pigment epithelial cells as early as 3 hours after light exposure followed by rose bengal injection, and this expression increased with time. Western blotting data showed that ADF expression increased in the retinal pigment epithelial cells in the experimental group, as compared with the control group. These results indicate that ADF is actively induced in retinal pigment epithelial cells upon oxidative stress.
CONCLUSIONS: ADF induction in retinal pigment epithelial cells may be involved in the defense mechanism against cellular damage caused by active oxygen species generated during oxygen stress to the retina.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139268

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

1.  Redox systems of the cell: possible links and implications.

Authors:  Kumuda C Das; Carl W White
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

2.  Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage.

Authors:  Y Takagi; A Mitsui; A Nishiyama; K Nozaki; H Sono; Y Gon; N Hashimoto; J Yodoi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischaemia and reperfusion in the rat.

Authors:  A Ohira; E de Juan; Y Tano; C A Wilson
Journal:  Histochem J       Date:  1996-09

4.  c-Jun-NH2 terminal kinase (JNK)-mediates AP-1 activation by thioredoxin: phosphorylation of cJun, JunB, and Fra-1.

Authors:  Kumuda C Das; Harish Muniyappa
Journal:  Mol Cell Biochem       Date:  2009-10-27       Impact factor: 3.396

5.  Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T Mutations.

Authors:  Jennifer E Gilda; Xianyin Lai; Frank A Witzmann; Aldrin V Gomes
Journal:  Mol Cell Proteomics       Date:  2016-03-28       Impact factor: 5.911

Review 6.  Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection.

Authors:  Hiroshi Masutani; Jie Bai; Yong-Chul Kim; Junji Yodoi
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

7.  Orally active multi-functional antioxidants are neuroprotective in a rat model of light-induced retinal damage.

Authors:  James Randazzo; Zifeng Zhang; Michael Hoff; Hiroyoshi Kawada; Andrew Sachs; Yang Yuan; Neena Haider; Peter Kador
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

8.  Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma.

Authors:  Mee-Kyung Cha; Kyung-Hoon Suh; Il-Han Kim
Journal:  J Exp Clin Cancer Res       Date:  2009-06-30

9.  Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.

Authors:  Byung-Joon Park; Mee-Kyung Cha; Il-Han Kim
Journal:  BMC Res Notes       Date:  2014-01-06

10.  The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.

Authors:  Youn Ju Lee; Young Kim; Bo Bae Choi; Je Ryong Kim; Hye Mi Ko; Kyoung Hoon Suh; Jin Sun Lee
Journal:  BMC Cancer       Date:  2022-01-03       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.